Massachusetts Lawmakers Prioritize Health Policy
Katherine O'Malley
August 12, 2026
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Steven Pinker published an editorial in the Boston Globe that scorned the profession of bioethics, telling them to “Get out of the way” of biomedical research.
In covering health care technology, it’s generally thought that commercial market plans follow Medicare’s lead. In particular, I’ve heard it stated that private plans tend
Sam Richardson recently joined the faculty at Boston College, where he is an Associate Professor of the Practice of Economics. He has also volunteered as
The following is a guest post by Jennifer Gilbert, a Clinical Research Coordinator at Massachusetts General Hospital. She graduated from Boston University in 2014. You
The following originally appeared on The Upshot (copyright 2015, The New York Times Company). Health care spending growth has moderated in recent years, but it’s still putting
I think I may just have to quit today… How’s that Medicare readmission-penalty pay-for-performance thing working out? In the fourth year of federal readmission penalties,
There are some days I just want to quit. From today’s NYT: In 2006, the National Cancer Institute took the rare step of issuing a
Defensive medicine refers to the idea that doctors are forced to order extra tests, perform extra procedures, or push for more office visits because they
I broached this subject before. Yesterday, in Health Affairs, Robert Berenson and colleagues offered some additional data. Long story short: Medicare Advantage (MA) plans appear
The following originally appeared on The Upshot (copyright 2015, The New York Times Company). Readers responded in great number to my recent column on artificial sweeteners. Many
From JAMA Internal Medicine, “Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial“: Importance Experts debate optimal 25-hydroxyvitamin D (25[OH]D) levels for musculoskeletal